Publications by authors named "Andreea M Bujor"

Background: Systemic sclerosis-related pulmonary hypertension (SSc-PH) is a heterogeneous disease, often complicated by concomitant left ventricular (LV) dysfunction. However, the contribution of heterogeneity in LV dysfunction is unclear. The objective in this study was to identify regional clusters of LV longitudinal strain via echocardiography to determine how subgroups of LV dysfunction contribute to mortality in SSc-PH.

View Article and Find Full Text PDF

Progressive lung fibrosis is associated with poorly understood aging-related endothelial cell dysfunction. To gain insight into endothelial cell alterations in lung fibrosis we performed single cell RNA-sequencing of bleomycin-injured lungs from young and aged mice. Analysis reveals activated cell states enriched for hypoxia, glycolysis and YAP/TAZ activity in ACKR1+ venous and TrkB+ capillary endothelial cells.

View Article and Find Full Text PDF
Article Synopsis
  • In systemic sclerosis (SSc), pulmonary hypertension (SSc-PH) is a major health concern, but the role of left ventricular (LV) dysfunction in this context is not well understood.
  • A study of 165 SSc patients found that 74.2% with SSc-PH had LV dysfunction, significantly impacting their survival rates compared to those without pulmonary hypertension.
  • The findings suggest that assessing LV dysfunction using global longitudinal strain could be crucial for evaluating risk and improving management strategies for patients with SSc-PH.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers created a scoring system to identify systemic sclerosis (SSc) patients at risk for pulmonary hypertension (PH) and predict their overall mortality using data from pulmonary function tests, echocardiograms, and chest CT scans.* -
  • In a study with 117 SSc patients, 51.3% were found to have PH, and the scoring tool demonstrated high sensitivity (0.87), specificity (0.74), and accuracy (0.80) for predicting PH.* -
  • Each one-point increase in the score was linked to a higher risk of all-cause mortality, indicating that with further validation, this tool could improve early detection of PH in SSc patients.*
View Article and Find Full Text PDF

Lung regeneration deteriorates with aging leading to increased susceptibility to pathologic conditions, including fibrosis. Here, we investigated bleomycin-induced lung injury responses in young and aged mice at single-cell resolution to gain insights into the cellular and molecular contributions of aging to fibrosis. Analysis of 52,542 cells in young (8 weeks) and aged (72 weeks) mice identified 15 cellular clusters, many of which exhibited distinct injury responses that associated with age.

View Article and Find Full Text PDF

Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive multiorgan fibrosis. While the cause of SSc remains unknown, a perturbed vasculature is considered a critical early step in the pathogenesis. Using fibrinogen as a marker of vascular leakage, we found extensive extravascular fibrinogen deposition in the dermis of both limited and diffuse systemic sclerosis disease, and it was present in both early and late-stage patients.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with systemic sclerosis-related pulmonary hypertension (SSc-PH) show a poorer response to PAH treatment and higher mortality rates compared to those with idiopathic PAH.
  • This study analyzed data from 39 SSc-PH patients to identify factors that predict their hemodynamic response to therapy, measured by a significant reduction in pulmonary vascular resistance.
  • Findings revealed that patients with lower pulmonary arterial wedge pressure (PAWP) had a significantly higher chance of achieving a positive hemodynamic response, highlighting the role of underlying cardiac issues in treatment efficacy.
View Article and Find Full Text PDF

Objectives: To mine the serum proteome of patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) and to detect biomarkers that may assist in earlier and more effective diagnosis and treatment.

Methods: Patients with limited cutaneous SSc, no extensive interstitial lung disease and no PAH-specific therapy were included. They were classified as cases if they had PAH confirmed by right heart catheterisation (RHC) and serum collected on the same day as RHC; and as controls if they had no clinical evidence of PAH.

View Article and Find Full Text PDF

Objective: To evaluate the levels of periostin in patients with systemic sclerosis (SSc) and their association with features of systemic sclerosis.

Methods: The levels of periostin were assessed in the serum of 106 SSc patients and 22 healthy controls and by immunofluorescence staining in cardiac tissue from 4 SSc patients and 4 controls. Serum periostin was measured via enzyme-linked immunosorbent assay.

View Article and Find Full Text PDF

Patients with systemic sclerosis complicated by both pulmonary hypertension (SSc-PH) and interstitial lung disease (SSc-PH-ILD) have poor prognosis compared to those with SSc-PH or SSc-ILD alone. Little is known of how ILD severity affects outcomes in those with SSc-PH, or how PH severity affects outcomes in those with SSc-ILD. Herein, we aimed to delineate clinical features of patients with SSc-PH and SSc-ILD and determine to what degree PH and ILD severity contribute to mortality in patients with SSc.

View Article and Find Full Text PDF

Background: The prognosis and therapeutic responses are worse for pulmonary arterial hypertension associated with systemic sclerosis (SSc-PAH) compared with idiopathic pulmonary arterial hypertension (IPAH). This discrepancy could be driven by divergence in underlying metabolic determinants of disease.

Research Question: Are circulating bioactive metabolites differentially altered in SSc-PAH vs IPAH, and can this alteration explain clinical disparity between these PAH subgroups?

Study Design And Methods: Plasma biosamples from 400 patients with SSc-PAH and 1,082 patients with IPAH were included in the study.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on improving the diagnosis of pulmonary hypertension (PH) in patients with systemic sclerosis (SSc) by using better prediction models to potentially reduce unnecessary invasive procedures like right heart catheterization (RHC).
  • Researchers analyzed data from 130 SSc patients, comparing three predictive models (random forest, classification and regression tree, logistic regression) to see which was most effective in identifying PH accurately.
  • The random forest model was found to be the most effective, achieving high sensitivity and specificity, with key predictors being pulmonary artery diameter and carbon monoxide diffusing capacity, which could help select patients who truly need RHC.
View Article and Find Full Text PDF
Article Synopsis
  • Systemic sclerosis-related pulmonary hypertension (SSc-PH) is a serious complication of systemic sclerosis that can lead to increased mortality, prompting the need for better prognostic tools.
  • A study reviewing ECGs of 169 patients found that right axis deviation (RAD) and left axis deviation (LAD) were common and linked to various cardiac abnormalities; RAD was more severe and associated with worse pulmonary hypertension outcomes compared to LAD.
  • Both RAD and LAD were significant predictors of increased all-cause mortality, highlighting the value of ECG in assessing risk for patients with SSc-PH.
View Article and Find Full Text PDF

Scleroderma (SSc) is an autoimmune connective tissue disease characterized by immune dysregulation, vasculopathy, and fibrosis. We have previously demonstrated that low Fli1 expression in SSc fibroblasts and endothelial cells plays an important role in SSc pathogenesis. Cells of myeloid and lymphoid origin also express Fli1 and are dysregulated in patients with SSc, playing key roles in disease pathogenesis.

View Article and Find Full Text PDF

Objective: Studies suggest that parenteral MTX may be more efficacious than the oral form at equivalent doses for the treatment of rheumatoid arthritis. We carried out a meta-analysis to compare the efficacy of oral versus parenteral MTX in RA.

Methods: PubMed, Web of Science and Embase were systematically searched from inception to June 8th 2017 and reviewed following PRISMA 2009 guidelines, by two independent reviewers.

View Article and Find Full Text PDF

BACKGROUND Increased serum levels of basic calcium phosphate (BCP) and calcium pyrophosphate (CPP) are found in patients on dialysis, following trauma, and are associated with connective tissue diseases (CTDs), including dermatomyositis, scleroderma, and systemic lupus erythematosus (SLE). The shoulder is the joint most commonly associated with BCP crystal periarthritis. A report is presented of a case of BCP crystal periarthritis involving the distal interphalangeal (DIP) joints in a patient with SLE.

View Article and Find Full Text PDF

Introduction: Adenosine, acting through the A(2A) receptor, promotes tissue matrix production in the skin and the liver and induces the development of dermal fibrosis and cirrhosis in murine models. Since expression of A(2A) receptors is increased in scleroderma fibroblasts, we examined the mechanisms by which the A(2A) receptor produces its fibrogenic effects.

Methods: The effects of A(2A) receptor ligation on the expression of the transcription factor, Fli1, a constitutive repressor for the synthesis of matrix proteins, such as collagen, is studied in dermal fibroblasts.

View Article and Find Full Text PDF

Objective: To explore the expression of thymic stromal lymphopoietin (TSLP) in patients with diffuse cutaneous systemic sclerosis (dcSSc) and compare its effects in vivo and in vitro with those of interleukin-13 (IL-13) and transforming growth factor β (TGFβ).

Methods: Skin biopsy specimens from patients with dcSSc (n = 14) and healthy controls (n = 13) were analyzed by immunohistochemistry and immunofluorescence for TSLP, TSLP receptor, CD4, CD8, CD31, and CD163 markers. Wild-type, IL-4Rα1-, and TSLP-deficient mice were treated with TGFβ, IL-13, poly(I-C), or TSLP by osmotic pump.

View Article and Find Full Text PDF

Systemic sclerosis (SSc) is characterized by fibrosis of the skin and internal organs. The present study was undertaken to examine the effects of ciprofloxacin, a fluoroquinolone antibiotic implicated in matrix remodeling, on dermal and lung fibroblasts obtained from SSc patients. Dermal and lung fibroblasts from SSc patients and healthy subjects were treated with ciprofloxacin.

View Article and Find Full Text PDF

Introduction: Systemic sclerosis (SSc) is an autoimmune inflammatory disorder of unknown etiology characterized by fibrosis of the skin and internal organs. Ang II (angiotensin II), a vasoconstrictive peptide, is a well-known inducer of kidney, heart, and liver fibrosis. The goal of this study was to investigate the profibrotic potential of Ang II in the mouse skin.

View Article and Find Full Text PDF

Background: Scleroderma (SSc) is characterized by excess production and deposition of extracellular matrix (ECM) proteins. Activated fibroblasts play a key role in fibrosis in SSc and are resistant to Fas-mediated apoptosis. Acid sphingomyelinase (ASMase), a major sphingolipid enzyme, plays an important role in the Fas-mediated apoptosis.

View Article and Find Full Text PDF

Previous studies have shown that the transforming growth factor (TGF)β/Alk1/Smad1 signaling pathway is constitutively activated in a subset of systemic sclerosis (SSc) fibroblasts and this pathway is a critical regulator of CCN2 gene expression. Caveolin-1 (cav-1), an integral membrane protein and the main component of caveolae, has also been implicated in SSc pathogenesis. This study was undertaken to evaluate the role of caveolin-1 in Smad1 signaling and CCN2 expression in healthy and SSc dermal fibroblasts.

View Article and Find Full Text PDF